ReviewEuropean urology focus2022

Optimal Selection of Patients with Genitourinary Cancers for Anti-PD1/PD-L1 Treatment with a Focus on Urothelial and Renal Cell Carcinoma.

Philip Zeuschner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.